News and PR

Sep
2020
5 Questions with Itamar Medical CEO Gilad Glick
Jul
2020
Sleep Testing Is Evolving. How Will It Look In the Near Future?
Apr
2020
Itamar™ Medical and BetterNight to Join Forces Offering Referred Patients Home Based Virtual-Care Sleep Solution for the Diagnosis and Treatment of Sleep Apnea
Mar
2020
Itamar™ Medical Implements Broad Range of Actions in Response to COVID-19 Pandemic
Mar
2020
Itamar™ Medical Reports Record Fourth Quarter and Full Year 2019 Revenues
Mar
2020
Itamar™ Medical and Clalit Research Institute Establish Research Collaboration to Explore WatchPAT Signals’ Ability to Predict Health Outcomes Using Existing Big Data and Artificial Intelligence
Feb
2020
ItamarTM Medical to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on Tuesday, March 3, 2020
Feb
2020
Itamar™ Medical Announces Publication of COMPASS Study Validating First Scoring Guidelines for WatchPAT™ Device in Diagnosing Sleep Apnea
Feb
2020
ItamarTM Medical Announces Closing of Upsized Public Offering of American Depositary Shares and Full Exercise of the Underwriters’ Option to Purchase Additional ADSs
Jan
2020
ItamarTM Medical Announces Upsizing and Pricing of Public Offering of American Depositary Shares
Jan
2020
ItamarTM Medical Announces Proposed $30 Million Offering of American Depositary Shares
Jan
2020
Itamar™ Medical Announces Preliminary Revenue for Fourth Quarter and Full Year 2019 and Revenue Guidance for Full Year 2020
Jan
2020
Itamar MedicalTM Selected to Participate in the Prestigious Weizmann Institute Project 10K
Dec
2019
ItamarTM Medical and SoClean® Announce Collaboration to Offer WatchPATTM ONE and other Digital Health Services Through Direct-to-Consumer Channels
Nov
2019
ItamarTM Medical reports record third quarter 2019 revenues
Nov
2019
ItamarTM Medical to Present at the Piper Jaffray 31st Annual Healthcare Conference on December 4, 2019
Nov
2019
ItamarTM Medical to Report Third Quarter 2019 Financial Results and Host Conference Call on Tuesday, November 26, 2019
Nov
2019
ItamarTM Medical Announces Blue Shield of CA and Blue Cross Blue Shield Federal Employee Plan to Include WatchPATTM in Their Policies
Oct
2019
ItamarTM Medical Appoints Jennifer Cook, MD, FAHA, FACC, as Global Medical Director
Oct
2019
ItamarTM Medical Advances Simple, Accurate and Reliable Home Sleep Apnea
Sep
2019
ItamarTM Medical to Present at the Ladenburg Thalmann 2019 Healthcare Conference on September 24, 2019
Aug
2019
ItamarTM Medical Reports Record Second Quarter 2019 Revenues
Jul
2019
ItamarTM Medical to Report Second Quarter 2019 Financial Results and Host Conference Call on Wednesday, August 14, 2019
Jun
2019
ItamarTM Medical WatchPATTM One 510k Clearance Final
Apr
2019
ItamarTM Medical reports first quarter 2019 financial results
Mar
2019
ItamarTM Medical Advances Simple, Accurate and Reliable Home Sleep Apnea Testing with Launch of WatchPATTM 300
Mar
2019
ItamarTM Medical Reports Fourth Quarter And Full Year 2018 Financial Results With Record Revenues
Mar
2019
ItamarTM Medical to Present at the Oppenheimer 29th Annual Healthcare Conference on March 20, 2019
Feb
2019
ItamarTM Medical to Commence Trading on Nasdaq
Feb
2019
ItamarTM Medical Announces that Publication on the Role of Obstructive Sleep Apnea in Atrial Fibrillation Selected for Inclusion in Circulation’s 2018 Year in Review
Feb
2019
ItamarTM Medical Partners with CardioVisual to Educate Patients and Healthcare Providers on the Importance of Sleep Apnea Testing and Streamline Cardiology Practice Workflow
Jan
2019
ItamarTM Medical Announces Definitive Agreements for $11.5 Million Private Placement
Nov
2018
ItamarTM Medical Reports Record Third Quarter 2018 Financial Results
Aug
2018
ItamarTM Medical Reports Second Quarter 2018 Financial Results
Aug
2018
ItamarTM Medical Announces Favorable CMS Reimbursement Decision to its WatchPAT™ Sleep Apnea Testing Device
May
2018
ItamarTM Medical reports record financial results for the first quarter, with 26% increase in revenue to $5.5 million and minimal operating loss
May
2018
ItamarTM Medical Launches SleePathTM, an Integrated Cloud-based Sleep Apnea Patient Care Pathway Management Tool for AFib Patients at Heart Rhythm 2018
May
2018
Itamar Medical Highlights New WatchPATTM Scoring Guidelines Based on the COMPASS(1) Study Results from Johns Hopkins Sleep Investigators at SLEEP 2018
Mar
2018
ItamarTM Medical Reports Fourth Quarter and Full Year 2017 Financial Results, Record Revenue of Nearly $21 million in 2017, Significant Decrease in Operating Loss.
Feb
2018
Airway Management announced a new partnership with ItamarTM Medical Ltd to distribute the myTAP oral appliance.
Jun
2017
FDA clearance for the new WatchPATTM Central Plus
Apr
2017
ItamarTM Medical BioTelemetry Collaboration
Jan
2017
EndoPATTM system may help measure cardiovascular risk from breast cancer treatment
Jun
2016
ItamarTM Medical Reports Success in Clinical Study Validating WatchPATTM for Central Sleep Apnea Differentiation, Submits Application for FDA Clearance of New WatchPATTM Version
May
2015
ItamarTM Medical Offers a Total Sleep Apnea Management Solution to Cardiologists
Apr
2015
New Agreement Puts ItamarTM Medical Inc. and Arterial Health International (AHI)
Sep
2014
Galmed Pharmaceuticals and ItamarTM Medical to Collaborate on Assessing Aramchol’s Effect on Endothelial Function.
Jun
2014
ItamarTM Medical Signs an Exclusive Distribution Agreement with Nihon Kohden Japan for Its EndoPAT Device
Jun
2014
ItamarTM Medical Launches WatchPATTM Unified
May
2014
ItamarTM Launches New Cloud Service
May
2014
Yelin Lapidot and Migdal Insurance to Invest NIS 23.6 Million in Itamar Medical in a Private Equity Placement New Agreement Puts ItamarTM Medical Inc. and Arterial Health International (AHI)